- Report
- April 2022
- 91 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- July 2024
- 153 Pages
Global
From €3211EUR$3,613USD£2,803GBP
€3777EUR$4,250USD£3,297GBP
- Report
- October 2023
- 79 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- August 2023
- 116 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- May 2023
- 103 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- June 2022
- 92 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- November 2024
- 96 Pages
Global
From €3500EUR$4,219USD£3,162GBP
- Report
- September 2025
- 23 Pages
Germany
From €995EUR$1,199USD£899GBP
- Report
- February 2025
- 204 Pages
United States
From €5328EUR$5,995USD£4,651GBP
- Report
- November 2025
- 132 Pages
Global
From €844EUR$950USD£737GBP
- Report
- January 2025
- 132 Pages
Global
From €844EUR$950USD£737GBP
- Report
- February 2025
- 44 Pages
United States
From €1071EUR$1,205USD£935GBP
The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more
